 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > MGI PHARMA, Inc.
 |
MGI PHARMA, Inc. |
 |
 |
 |
PROFILE |
 |
MGI PHARMA finds homes for orphan drugs. Focusing on oncology, the company buys and develops drugs that probably won't be best sellers but will fit small medical niches. MGI tries to reduce the risk of product failure by buying drug candidates past the initial discovery stage. Its flagship product, Salagen Tablets, treats radiation-induced chronic dry mouth in head and neck cancer patients and in patients with Sjogren's Syndrome. Other products include Didronel IV Infusion, used to treat a life-threatening metabolic disorder associated with cancer, and Hexalen Capsules, a second-line chemotherapy for ovarian cancer. MGI has returned rights to the rheumatology drugs it distributed from Connetics and Pharmacia.
COMPETITION |
 |
Neurobiological Technologies, Inc. (NTII)
Snow Brand Milk Products Co., Ltd. (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 25.20
1-Yr. Sales Growth: 2.0%
Employees: 133
Revenue per employee: $189,473.68
KEY PEOPLE |
 |
Charles N. Blitzer
CEO
William C. Brown
CFO
CONTACT INFO |
 |
6300 W. Old Shakopee Rd.
Bloomington, MN 55343
US
Phone: 952-346-4700
Fax: 952-346-4800
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |